Abstract-Various derivatives of glaziovianin A, an antitumor isoflavone, were synthesized, and the cytotoxicity of each against HeLa S 3 cells was investigated. Compared to glaziovianin A, the O 7 -allyl derivative was found to be more cytotoxic against HeLa S 3 cells and a more potent M-phase inhibitor.
In 2007, glaziovianin A (1) was isolated from the leaves of the Brazilian tree Astelia glazioviana by Yokosuka et al. (Fig. 1) . 1 Glaziovianin A (1) exhibited cytotoxicity against HL-60 cells with an IC 50 value of 0.29 M. Also, glaziovianin A (1) was evaluated against a panel of 39 human cancer cell lines (termed JFCR39) at the Japanese Foundation for Cancer Research. The pattern of the differential cytotoxicities of glaziovianin A (1) has suggested that the activity of glaziovianin A (1) involves the inhibition of tubulin polymerization as a mechanism of action. 2 Inhibitors of tubulin polymerization have become clinically important drugs against breast cancer. Because glaziovianin A showed antitumor activities in a mouse xenograft model (unpublished data), we think that modification of glaziovianin A (1) can lead to the discovery of novel compounds that possess antitumor activity and that inhibit tubulin polymerization. In this paper, we report the structure-activity relationship study of glaziovianin A (1). We previously reported the synthesis of glaziovianin A (1) by using Suzuki-Miyaura coupling as a key step (Scheme 1). 3 The method of synthesizing glaziovianin A analogues was based on our previous strategy. To develop analogues of glaziovianin A (1), its structure can be divided into two structural moieties: an A-ring and a B-ring (Fig. 2) . Therefore, we synthesized 3-iodochromone derivatives as an A-ring and borone compounds as a B-ring. First, we tried to modify a methylene acetal part at the B-ring of glaziovianin A (Scheme 2). The diol group in 3,6-dimethoxybenzene-1,2-diol (6) was converted to compound 7. The bromination of compound 7 gave a monobromo compound, which was converted into arylboronate 8. 4 2,3,4,5-Tetramethoxyphenylboronic acid (10) was prepared by the lithiation of 1,2,3,4-tetramethoxybenzene (9) followed by treatment with trimethyl borate. 5 The Suzuki-Miyaura coupling 6 of 3-iodo-6,7-dimethoxy-4H-chromen-4-one (3) 3 with boron compounds, such as arylboronate 8, 2,3,4,5-tetramethoxyphenylboronic acid (10), or commercially available 3,4-(methylenedioxy)phenylboronic acid (11), afforded glaziovianin A analogues 12-14, respectively. Scheme 2. Synthesis of B-ring analogues of glaziovianin A. Reagents and conditions: (a) 2-methoxypropene, PPTS, benzene, rt, 72%; (b) NBS, DMF, rt, 69%; (c) bis(pinacolato)diboron, PdCl 2 (dppf), KOAc, DMF, 150 °C, 28%; (d) n-BuLi, B(OMe) 3 , THF, rt; (e) 3, PdCl 2 (dppf), 1 M Na 2 CO 3 aq., 1,4-dioxane, rt {64% for 12, 11% for 13 (from 9), 41% for 14}.
Next, we prepared A-ring analogues. Selective protection of the hydroxy group at the C7 position of 15 7 afforded compound 16 (Scheme 3). Condensation of 16 with N,N-dimethylformamide dimethyl acetal gave an enamine, which was converted to iodochromone 17. 8 We tried a cross coupling reaction with arylboronate 5 3 and iodochromone compounds, such as 17 or 18 9 , to provide compounds 19 and 20, respectively. The THP group in 19 was removed by using p-TsOH·H 2 O to give a 7-hydroxy derivative (21), which is a suitable precursor for the synthesis of glaziovianin derivatives. Conversion of the hydroxy group at C7 in 21 into various ethers afforded benzyl ether 22, propargyl ether 23, and allyl ether 24. Table 1 summarizes the cytotoxicity of glaziovianin A (1) and its analogues against HeLa S 3 cells. 10 Compound 12, which has an acetonide group instead of the methylene acetal group, showed no cytotoxicity even at 100M. Also, compound 13, which has four methoxy groups at the B-ring, was about 40-fold less cytotoxic than glaziovianin A (1). These results indicated that steric hindrance of C3' and C4' at the Bring part was shown to reduce cytotoxicity to a large extent. Compound 14, which lacks methoxy groups at C2' and C5', was less cytotoxic than glaziovianin A (1), which indicated that the electron density of the B-ring might be essential for cytotoxicity. On the other hand, compound 20, which has an extra methoxy group at C5 of the A-ring, showed no cytotoxicity at 100M. This result showed that the steric hindrance and electron density of the A-ring reduced cytotoxicity to a large extent. While the 7-demethyl derivative 21 exhibited no cytotoxicity, compounds 22-24, which each have an alkyl group at O 7 instead of the methyl group, showed cytotoxicity with IC 50 values of 0.75, 0.74, and 0.19 M, respectively. Furthermore, compound 19, which has a THP group at O 7 , showed no cytotoxicity even at 100M. These results indicated that the hydrophobicity of the O 7 -alkyl group in glaziovianin derivatives is important for cytotoxicity. However, the THP group seems to be too large. It is worth noting that allyl ether 24 11 is more active than glaziovianin A (1) itself. We previously reported that glaziovianin A (1) inhibited the cell cycle progression in the M-phase with abnormal spindle structures. 1 Therefore, we next investigated the effects of the most cytotoxic compound, 24, on both cell cycle progression 12 and spindle structures 13 ( Figure 3 ). As with glaziovianin A (1), compound 24 inhibited cell cycle progression in M-phase, and 24-treated cells showed abnormal spindle structures with unaligned chromosomes at the concentration of 1 µM after 18 h treatment: these phenotypes were stronger than those of 1 µM glaziovianin A (1) treatment, suggesting that compound 24 is a more potent M-phase inhibitor than the original compound glaziovianin A (1). 
